ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability
Eisai and MSD presented the data at the European Society for Medical Oncology (ESMO) Congress 2025.
21 October 2025
21 October 2025
Eisai and MSD presented the data at the European Society for Medical Oncology (ESMO) Congress 2025.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.